BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 15811955)

  • 1. Familial risk for non-Hodgkin lymphoma and other lymphoproliferative malignancies by histopathologic subtype: the Swedish Family-Cancer Database.
    Altieri A; Bermejo JL; Hemminki K
    Blood; 2005 Jul; 106(2):668-72. PubMed ID: 15811955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Family history of hematopoietic malignancy and risk of lymphoma.
    Chang ET; Smedby KE; Hjalgrim H; Porwit-MacDonald A; Roos G; Glimelius B; Adami HO
    J Natl Cancer Inst; 2005 Oct; 97(19):1466-74. PubMed ID: 16204696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No evidence for anticipation in lymphoproliferative tumors in population-based samples.
    Daugherty SE; Pfeiffer RM; Mellemkjaer L; Hemminki K; Goldin LR
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1245-50. PubMed ID: 15894680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial cancers associated with subtypes of leukemia and non-Hodgkin's lymphoma.
    Pottern LM; Linet M; Blair A; Dick F; Burmeister LF; Gibson R; Schuman LM; Fraumeni JF
    Leuk Res; 1991; 15(5):305-14. PubMed ID: 2046383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-hodgkin lymphoma risk and insecticide, fungicide and fumigant use in the agricultural health study.
    Alavanja MC; Hofmann JN; Lynch CF; Hines CJ; Barry KH; Barker J; Buckman DW; Thomas K; Sandler DP; Hoppin JA; Koutros S; Andreotti G; Lubin JH; Blair A; Beane Freeman LE
    PLoS One; 2014; 9(10):e109332. PubMed ID: 25337994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial aggregation and heterogeneity of non-Hodgkin lymphoma in population-based samples.
    Goldin LR; Landgren O; McMaster ML; Gridley G; Hemminki K; Li X; Mellemkjaer L; Olsen JH; Linet MS
    Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2402-6. PubMed ID: 16214923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex- and kindred-specific familial risk of non-Hodgkin's lymphoma.
    Czene K; Adami HO; Chang ET
    Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2496-9. PubMed ID: 18006943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk for malignancies of infectious etiology among adult survivors of specific non-Hodgkin lymphoma subtypes.
    Herr MM; Schonfeld SJ; Dores GM; Engels EA; Tucker MA; Curtis RE; Morton LM
    Blood Adv; 2019 Jul; 3(13):1961-1969. PubMed ID: 31262739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inheritance in lymphoproliferative disorders].
    Jønsson V; Olsen JH
    Ugeskr Laeger; 2006 Jun; 168(24):2361-6. PubMed ID: 16822421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial risk of lymphoproliferative tumors in families of patients with chronic lymphocytic leukemia: results from the Swedish Family-Cancer Database.
    Goldin LR; Pfeiffer RM; Li X; Hemminki K
    Blood; 2004 Sep; 104(6):1850-4. PubMed ID: 15161669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated risk of chronic lymphocytic leukemia and other indolent non-Hodgkin's lymphomas among relatives of patients with chronic lymphocytic leukemia.
    Goldin LR; Björkholm M; Kristinsson SY; Turesson I; Landgren O
    Haematologica; 2009 May; 94(5):647-53. PubMed ID: 19286886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia patients: a population-based study in Sweden.
    Kristinsson SY; Björkholm M; Goldin LR; McMaster ML; Turesson I; Landgren O
    Blood; 2008 Oct; 112(8):3052-6. PubMed ID: 18703425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial risk of non-Hodgkin lymphoma by sex, relationship, age at diagnosis and histology: a joint study from five Nordic countries.
    Fallah M; Kharazmi E; Pukkala E; Tretli S; Olsen JH; Tryggvadottir L; Sundquist K; Hemminki K
    Leukemia; 2016 Feb; 30(2):373-8. PubMed ID: 26442613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of non-Hodgkin lymphoma subtypes in HIV-infected people during the HAART era: a population-based study.
    Gibson TM; Morton LM; Shiels MS; Clarke CA; Engels EA
    AIDS; 2014 Sep; 28(15):2313-8. PubMed ID: 25111081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale and Design of the International Lymphoma Epidemiology Consortium (InterLymph) Non-Hodgkin Lymphoma Subtypes Project.
    Morton LM; Sampson JN; Cerhan JR; Turner JJ; Vajdic CM; Wang SS; Smedby KE; de Sanjosé S; Monnereau A; Benavente Y; Bracci PM; Chiu BC; Skibola CF; Zhang Y; Mbulaiteye SM; Spriggs M; Robinson D; Norman AD; Kane EV; Spinelli JJ; Kelly JL; La Vecchia C; Dal Maso L; Maynadié M; Kadin ME; Cocco P; Costantini AS; Clarke CA; Roman E; Miligi L; Colt JS; Berndt SI; Mannetje A; de Roos AJ; Kricker A; Nieters A; Franceschi S; Melbye M; Boffetta P; Clavel J; Linet MS; Weisenburger DD; Slager SL
    J Natl Cancer Inst Monogr; 2014 Aug; 2014(48):1-14. PubMed ID: 25174022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune diseases associated with non-Hodgkin lymphoma: a nationwide cohort study.
    Fallah M; Liu X; Ji J; Försti A; Sundquist K; Hemminki K
    Ann Oncol; 2014 Oct; 25(10):2025-2030. PubMed ID: 25081899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of cutaneous T-cell lymphoma in patients with chronic lymphocytic leukemia and other subtypes of non-Hodgkin lymphoma.
    Chang TW; Weaver AL; Shanafelt TD; Habermann TM; Wriston CC; Cerhan JR; Call TG; Brewer JD
    Int J Dermatol; 2017 Nov; 56(11):1125-1129. PubMed ID: 28685851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone replacement therapy and risk of non-hodgkin lymphoma and chronic lymphocytic leukemia.
    Cerhan JR; Vachon CM; Habermann TM; Ansell SM; Witzig TE; Kurtin PJ; Janney CA; Zheng W; Potter JD; Sellers TA; Folsom AR
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1466-71. PubMed ID: 12433728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of familial malignancy in a prospectively screened cohort of patients with lymphoproliferative disorders.
    Brown JR; Neuberg D; Phillips K; Reynolds H; Silverstein J; Clark JC; Ash M; Thompson C; Fisher DC; Jacobsen E; LaCasce AS; Freedman AS
    Br J Haematol; 2008 Nov; 143(3):361-8. PubMed ID: 18729853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer risk in amyloidosis patients in Sweden with novel findings on non-Hodgkin lymphoma and skin cancer.
    Hemminki K; Li X; Försti A; Sundquist J; Sundquist K
    Ann Oncol; 2014 Feb; 25(2):511-8. PubMed ID: 24406424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.